SCIF 2013
SICKLE CELL IN FOCUS 2013
Sickle Cell in Focus (SCiF), 6 - 8 June 2013, King's College London, Denmark Hill campus (EHA-CME accredited: 15 points)
Once again, we had an overwhelmingly fantastic response to Sickle Cell in Focus this year, our 7th year of holding this event. The feedback has been excellent and we thank our speakers and delegates for contributing to SCiF’s success.
PROGRAMME
THURSDAY 6 JUNE 2013
SESSION 1 Sickle cell disease in adults
Sickle cell disease: a global health problem – Sir David Weatherall, Weatherall Institute of Molecular Medicine, UK
Health maintenance in adults with sickle cell disease: a UK perspective – Jo Howard, Guy’s & St. Thomas’ NHS Foundation Trust
SESSION 2 Evolving Concepts and Emerging Therapies
Fetal haemoglobin: genetics to molecular mechanisms to targeted therapy – Swee Lay Thein, King’s College London / King’s College Hospital NHS Foundation Trust, UK
Biomarkers in sickle cell disease – David Rees, King’s College London / King’s College Hospital NHS Foundation Trust, UK
Update on clinical trials – Carolyn Hoppe, Children’s Hospital Oakland, USA
Globin gene transfer for the treatment of the thalassemias and hemoglobinopathies – Michel Sadelain, Sloan-Kettering Institute, USA
SESSION 3 Mini-Symposium: Sickle Hepatopathy
Liver imaging: how useful is it? – Pauline Kane, King’s College Hospital NHS Foundation Trust, UK
Liver pathology – Alberto Quaglia, King’s College Hospital NHS Foundation Trust, UK
Liver complications – Abid Suddle, King’s College Hospital NHS Foundation Trust, UK
SESSION 4 Debate: Is it justified to perform bone marrow transplant in sickle cell anaemia using unrelated and/or partially mismatched donors?
Yes – John Tisdale, National Institute of Health, USA
No – Miguel Abboud, American University of Beirut Medical Center, Lebanon
Day one close and network drinks (James Black Centre foyer)
FRIDAY 7 JUNE 2013
SESSION 1 Complications in adults with sickle cell disease
Avascular necrosis – Marcus Bankes, Guy’s & St. Thomas’ NHS Foundation Trust, UK
Leg ulceration associated with sickle cell disease – Richard Bull, Homerton University Hospital / Barts and the London,UK
Ophthalmologic complications – Sobha Sivaprasad, King’s College Hospital NHS Foundation Trust, UK
SESSION 2 Impact of New Technology in Sickle Cell Disease
Reproductive options: pre-implantation genetic diagnosis – Tarek El-Touhky, Guy’s & St. Thomas’ NHS Foundation Trust, UK
Current and future trends in prenatal diagnosis in sickle cell disease – Barnaby Clark, King’s College Hospital NHS Foundation Trust, UK
Personalised medicine: a reality for sickle cell disease? – Martin Steinberg, Boston University School of Medicine, USA
SESSION 3 Complications in adults with sickle cell disease
The many facets of sickle cell priapism – Nick Watkin, St. George’s Hospital, UK
Renal complications – Claire Sharpe, King’s College London / King’s College Hospital NHS Foundation Trust, UK
Free session (delegate case presentations)
SESSION 4 Mini-Symposium: Vascular Pathobiology
Vascular pathology in sickle cell disease – Paul Frenette, Albert Einstein College of Medicine, USA
Modelling of microvascular occlusion using microfluidic technology – Wilbur Lam, Emory University School of Medicine, USA
Pulmonary hypertension – Gerald Simonneau, Hôpital Kremlin Bicêtre, France
Cerebrovascular disease in adults with sickle cell disease – Elliott Vichinsky, Children’s Hospital Oakland, USA
Day two close
SATURDAY 8 JUNE 2013
SESSION 1
The many pathophysiologies of sickle cell disease: six blind men and the elephant – Abdullah Kutlar, Medical College Georgia, USA
Blood transfusion and alloimmunisation – Marilyn Telen, Duke University Medical Center
Free session (delegate case presentations)
SESSION 2
Debate: Blood Transfusion Therapy in Sickle Cell Disease – Should We Be Doing More?
Yes – John Porter, University College London Hospitals, UK
No – Graham R. Serjeant, Sickle Cell Trust, Jamaica
CONFERENCE CLOSE
Testimonials
Here is what some of this year’s attendees had to say:
“This was my first time at such a conference. I found it very informative and it raised questions about clinical treatment and practice, which is essential to ensure clients receive the most appropriate care”
“An excellent conference from all aspects. The speakers were excellent and the contributions from everyone was good”
“A very educational conference. Thoroughly enjoyed the entire conference and look forward to next year”
“Very good meeting overall. Thank you”
“Excellent value for time/money. Excellent organisation. Thanks!”
“Excellent selection of topics/speakers”
“Great meeting!”
“Very informative, good speakers, good balance of science and clinical presentations”
“This has been the best conference I’ve attended. Each speaker gave fantastic presentations. I think timing and structure was perfect. Please continue the fantastic work!”
“Keep up the good organisation of the programme. There were numerous opportunities to meet people and expand my knowledge”